Your browser doesn't support javascript.
loading
Classification of Intrahepatic Cholangiocarcinoma into Perihilar Versus Peripheral Subtype.
Wei, Tao; Lu, Jianfeng; Xiao, Xue-Lian; Weiss, Matthew; Popescu, Irinel; Marques, Hugo P; Aldrighetti, Luca; Maithel, Shishir K; Pulitano, Carlo; Bauer, Todd W; Shen, Feng; Poultsides, George A; Soubrane, Oliver; Martel, Guillaume; Koerkamp, Bas Groot; Itaru, Endo; Lv, Yi; Zhang, Xu-Feng; Pawlik, Timothy M.
Afiliação
  • Wei T; Department of Hepatobiliary Surgery and Institute of Advanced Surgical Technology and Engineering, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.
  • Lu J; Department of Hepatobiliary and Pancreatic Surgery, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
  • Xiao XL; Department of Hepatobiliary and Pancreatic Surgery, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
  • Weiss M; Department of Hepatobiliary Surgery and Institute of Advanced Surgical Technology and Engineering, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.
  • Popescu I; Department of Surgery, The Urban Meyer III and Shelley Meyer Chair for Cancer Research, The Ohio State University Wexner Medical Center, Columbus, OH, USA.
  • Marques HP; Department of Surgery, Johns Hopkins Hospital, Baltimore, MD, USA.
  • Aldrighetti L; Department of Surgery, Fundeni Clinical Institute, Bucharest, Romania.
  • Maithel SK; Department of Surgery, Curry Cabral Hospital, Lisbon, Portugal.
  • Pulitano C; Department of Surgery, Ospedale San Raffaele, Milan, Italy.
  • Bauer TW; Department of Surgery, Emory University, Atlanta, GA, USA.
  • Shen F; Department of Surgery, Royal Prince Alfred Hospital, University of Sydney, Sydney, Australia.
  • Poultsides GA; Department of Surgery, University of Virginia, Charlottesville, VA, USA.
  • Soubrane O; Department of Surgery, Eastern Hepatobiliary Surgery Hospital, Shanghai, China.
  • Martel G; Department of Surgery, Stanford University, Stanford, CA, USA.
  • Koerkamp BG; Department of Hepatobiliopancreatic Surgery and Liver Transplantation, AP-HP, Beaujon Hospital, Clichy, France.
  • Itaru E; Division of General Surgery, Department of Surgery, University of Ottawa, Ottawa, ON, Canada.
  • Lv Y; Department of Surgery, Erasmus University Medical Centre, Rotterdam, The Netherlands.
  • Zhang XF; Gastroenterological Surgery Division, Yokohama City University School of Medicine, Yokohama, Japan.
  • Pawlik TM; Department of Hepatobiliary Surgery and Institute of Advanced Surgical Technology and Engineering, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.
Ann Surg Oncol ; 31(2): 1232-1242, 2024 Feb.
Article em En | MEDLINE | ID: mdl-37930500
BACKGROUND: Intrahepatic cholangiocarcinoma (ICC) constitutes a group of heterogeneous malignancies within the liver. We sought to subtype ICC based on anatomical origin of tumors, as well as propose modifications of the current classification system. METHODS: Patients undergoing curative-intent resection for ICC, hilar cholangiocarcinoma (CCA), or hepatocellular carcinoma (HCC) were identified from three international multi-institutional consortia of databases. Clinicopathological characteristics and survival outcomes were assessed. RESULTS: Among 1264 patients with ICC, 1066 (84.3%) were classified as ICC-peripheral subtype, whereas 198 (15.7%) were categorized as ICC-perihilar subtype. Compared with ICC-peripheral subtype, ICC-perihilar subtype was more often associated with aggressive tumor characteristics, including a higher incidence of nodal metastasis, macro- and microvascular invasion, perineural invasion, as well as worse overall survival (OS) (median: ICC-perihilar 19.8 vs. ICC-peripheral 37.1 months; p < 0.001) and disease-free survival (DFS) (median: ICC-perihilar 12.8 vs. ICC-peripheral 15.2 months; p = 0.019). ICC-perihilar subtype and hilar CCA had comparable OS (19.8 vs. 21.4 months; p = 0.581) and DFS (12.8 vs. 16.8 months; p = 0.140). ICC-peripheral subtype tumors were associated with more advanced tumor features, as well as worse survival outcomes versus HCC (OS, median: ICC-peripheral 37.1 vs. HCC 74.3 months; p < 0.001; DFS, median: ICC-peripheral 15.2 vs. HCC 45.5 months; p < 0.001). CONCLUSIONS: ICC should be classified as ICC-perihilar and ICC-peripheral subtype based on distinct clinicopathological features and survival outcomes. ICC-perihilar subtype behaved more like carcinoma of the bile duct (i.e., hilar CCA), whereas ICC-peripheral subtype had features and a prognosis more akin to a primary liver malignancy.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias dos Ductos Biliares / Colangiocarcinoma / Carcinoma Hepatocelular / Neoplasias Hepáticas Limite: Humans Idioma: En Revista: Ann Surg Oncol Assunto da revista: NEOPLASIAS Ano de publicação: 2024 Tipo de documento: Article País de afiliação: China

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias dos Ductos Biliares / Colangiocarcinoma / Carcinoma Hepatocelular / Neoplasias Hepáticas Limite: Humans Idioma: En Revista: Ann Surg Oncol Assunto da revista: NEOPLASIAS Ano de publicação: 2024 Tipo de documento: Article País de afiliação: China